ClinicalTrials.Veeva

Menu

Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease

D

Daewoong Pharmaceutical

Status

Unknown

Conditions

MCA - Middle Cerebral Artery Dissection

Treatments

Drug: Clopidogrel

Study type

Observational

Funder types

Industry

Identifiers

NCT02953405
DW_CLO001

Details and patient eligibility

About

Prescription and Persistence of Antithrombotic agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients with MCA(Middle Cerebral Artery) Disease.

Enrollment

1,000 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 19 years later, men and women

Exclusion criteria

  • Subject who is judged to be ineligible by investigator

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems